Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jenkins

Showing results (721-730 of 799) with videos related to

Pageof 80
Sort By:
Journal of Neuropathology and Experimental Neurology|March 19, 2025
Expanding the spectrum of TERT promoter mutations in CNS tumors: A case series of non-canonical mutationsDavid J Cook, Jorge A Trejo-Lopez, Beth A Pitel, et al.
The Journal of Urology|April 17, 2002
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urineKevin C Halling, Walter King, Irina A Sokolova, et al.
Journal of Neuropathology and Experimental Neurology|April 25, 2025
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?David J Cook, Paul A Decker, Jayson J Hardcastle, et al.
The Journal of Molecular Diagnostics : JMD|February 7, 2021
RNA-Seq Reveals Differences in Expressed Tumor Mutation Burden in Colorectal and Endometrial Cancers with and without Defective DNA-Mismatch RepairMargaret A DiGuardo, Jaime I Davila, Rory A Jackson, et al.
Nature Communications|November 22, 2014
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancerDimple Chakravarty, Andrea Sboner, Sujit S Nair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
Journal of Neurology|April 25, 2018
Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case-control studyShala G Berntsson, Ryan T Merrell, E Susan Amirian, et al.
Cancer Research Communications|May 4, 2026
MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell LymphomaMana Moassefi, Paul A Decker, Gian Marco Conte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trialEdith A Perez, Robert B Jenkins, Amylou C Dueck, et al.
Neuro-Oncology|May 10, 2020
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20CJeanette E Eckel-Passow, Kristen L Drucker, Thomas M Kollmeyer, et al.
Pageof 80

Showing results (721-730 of 799) with videos related to

Sort By:
Pageof 80
Journal of Neuropathology and Experimental Neurology|March 19, 2025
Expanding the spectrum of TERT promoter mutations in CNS tumors: A case series of non-canonical mutationsDavid J Cook, Jorge A Trejo-Lopez, Beth A Pitel, et al.
The Journal of Urology|April 17, 2002
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urineKevin C Halling, Walter King, Irina A Sokolova, et al.
Journal of Neuropathology and Experimental Neurology|April 25, 2025
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?David J Cook, Paul A Decker, Jayson J Hardcastle, et al.
The Journal of Molecular Diagnostics : JMD|February 7, 2021
RNA-Seq Reveals Differences in Expressed Tumor Mutation Burden in Colorectal and Endometrial Cancers with and without Defective DNA-Mismatch RepairMargaret A DiGuardo, Jaime I Davila, Rory A Jackson, et al.
Nature Communications|November 22, 2014
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancerDimple Chakravarty, Andrea Sboner, Sujit S Nair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
Journal of Neurology|April 25, 2018
Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case-control studyShala G Berntsson, Ryan T Merrell, E Susan Amirian, et al.
Cancer Research Communications|May 4, 2026
MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell LymphomaMana Moassefi, Paul A Decker, Gian Marco Conte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trialEdith A Perez, Robert B Jenkins, Amylou C Dueck, et al.
Neuro-Oncology|May 10, 2020
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20CJeanette E Eckel-Passow, Kristen L Drucker, Thomas M Kollmeyer, et al.
Pageof 80